1. World Health Organisation. Childhood overweight and
obesity. 2008. www.who.int/dietphysicalactivity/childhood/en/index.html.
Accessed on August 15, 2010.
2. Devi S. Progress on childhood obesity patchy in the
USA. Lancet 2008; 371: 105-106.
3. Agirbasli M, Cakir S, Ozme S, Ciliv G. Metabolic
syndrome in Turkish children and adolescents. Metabolism 2006; 55:
1002-1006.
4. Olds TS, Tomkinson GR, Ferrar KE, Maher CA. Trends
in the prevalence of childhood overweight and obesity in Australia between
1985 and 2008. Int J Obes (Lond) 2009; Oct 13: [Epub ahead of print].
5. Ji CY, Cheng TO. Epidemic increase in overweight and
obesity in Chinese children from 1985 to 2005. Int J Cardiol 2009; 132:
1-10.
6. Branca F, Nikogosian H, Lobstein T (eds). The
Challenge of Obesity in the WHO European Region and the Strategies for
Response. Copenhagen, WHO Regional Office for Europe 2007.
7. Greydanus DE, Bhave S. Obesity and adolescents; time
for increased physical activity. Indian Pediatr 2004; 41: 545-550.
8. Aziz S, Noorulain W, Zaidi UE, Hossain K, Siddiqui
IA. Prevalence of overweight and obesity among children and adolescents of
affluent schools in Karachi. J Pak Med Assoc 2009; 59: 35-38.
9. Ziraba AK, Fotso JC, Ochako R. Overweight and
obesity in urban Africa: A problem of the rich or the poor? BMC Public
Health 2009 ; 9: 465-473.
10. Gregor MF, Hotamisligil GS. Adipocyte stress: the
endoplasmic reticulum and metabolic disease. J Lipid Res 2007; 48:
1905-1914.
11. Trayhurn P. Adipocyte biology. Obes Rev 2007; 8:
41-44.
12. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H,
Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from
stomach. Nature 1999; 402: 656-660.
13. Klok MD, Jakobsdottir S, Drent ML. The role of
leptin and ghrelin in the regulation of food intake and body weight in
humans: a review. Obes Rev 2007; 8: 21-34.
14. Cummings DE, Purnell JQ, Frayo RS, Schmidova K,
Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests
a role in meal initiation in humans. Diabetes 2001; 50: 1714-1719.
15. Foster CM, Barkan A, Kasa-Vubu JZ, Jaffe C. Ghrelin
concentrations reflect body mass index rather than feeding status in obese
girls. Pediatr Res 2007; 6: 731-733.
16. Zou CC, Liang L, Wang CL, Fu JF, Zhao ZY. The
change in ghrelin and obestatin levels in obese children after weight
reduction. Acta Paediatr 2009; 98: 159-165.
17. Stylianou C, Galli-Tsinopoulou A, Farmakiotis D,
Rousso I, Karamouzis M, Koliakos G, et al. Ghrelin and leptin
levels in obese adolescents. Relationship with body fat and insulin
resistance. Hormones (Athens) 2007; 6: 295-303.
18. Galli-Tsinopoulou A, Stylianou C, Farmakiotis D,
Rousso I, Karamouzis M, Nousia-Arvanitakis S. Ghrelin serum levels during
oral glucose tolerance test in prepubertal obese children with insulin
resistance. J Pediatr Endocrinol Metab 2007; 20: 1085-1092.
19. Maffeis C, Bonadonna C, Consolaro A, Vettor R,
Banzato C, Silvagni D, et al. Ghrelin, insulin sensitivity and
postprandial glucose disposal in overweight and obese children. Eur J
Endocrinol 2006; 154: 61-68.
20. Iñiguez G, Ong K, Peña V, Avila A, Dunger D, Mericq
V. Fasting and post-glucose ghrelin levels in SGA infants: relationships
with size and weight gain at one year of age. J Clin Endocrinol Metab
2002; 87: 5830-5833.
21. Krohn K, Boczan C, Otto B, Heldwein W, Landgraf R,
Bauer CP, Koletzko B. Regulation of ghrelin is related to estimated
insulin sensitivity in obese children. Int J Obes (Lond) 2006; 30:
1482-1487.
22. Bellone S, Rapa A, Vivenza D, Castellino N, Petri
A, Bellone J, et al. Circulating ghrelin levels as function of
gender, pubertal status and adiposity in childhood. J Endocrinol Invest
2002; 25: 13-15.
23. Xiu-Min Wang, You-Jun Jiang, Li Liang, Li-Zhong Du.
Changes of ghrelin following oral glucose tolerance test in obese children
with insulin resistance. World J Gastroenterol 2008; 14: 1919-1924.
24. Chao-Chun Zou, Li Liang, Zheng-Yan Zhao. Factors
associated with fasting plasma ghrelin levels in children and adolescents.
World J Gastroenterol 2008; 14: 790-794.
25. Okamatsu Y, Matsuda K, Hiramoto I, Tani H, Kimura
K, Yada Y, et al. Ghrelin and leptin modulate immunity and liver
function in overweight children. Pediatr Int 2009; 51: 9-13.
26. Zhao CM, Furnes MW, Stenström B, Kulseng B, Chen D.
Characterization of obestatin- and ghrelin-producing cells in the
gastrointestinal tract and pancreas of rats: an immunohistochemical and
electron-microscopic study. Cell Tissue Res 2008; 331: 575-587.
27. Furnes WM, Stenstrom B, Tommeras K, Skoglund T,
Dickson SL, Kulseng B, et al. Feeding behaviour in rats subjected
to gastrectomy or gastric bypass surgery. Eur Surg Res 2008; 40: 279-288.
28. Huda MS, Durham BH, Wong SP, Deepak D, Kerrigan D,
McCulloch P, et al. Plasma obestatin levels are lower in obese and
post-gastrectomy subjects, but do not change in response to a meal. Int J
Obes (Lond) 2008; 32: 129-135.
29. Guo ZF, Zheng X, Qin YW, Hu JQ, Chen SP, Zhang Z.
Circulating preprandial ghrelin to obestatin ratio is increased in human
obesity. J Clin Endocrinol Metab 2007; 92: 1875-1880.
30. Reinehr T, de Sousa G, Roth CL. Obestatin and
ghrelin levels in obese children and adolescents before and after
reduction of overweight. Clin Endocrinol (Oxf) 2008; 68: 304-310.
31. Antunes H, Santos C, Carvalho S. Serum leptin
levels in overweight children and adolescents. Br J Nutr 2008; 28: 1-5.
32. Holm JC, Gamborg M, Kaas-Ibsen K, Gammeltoft S,
Ward L, Heitmann BL, et al. Time course and determinants of leptin
decline during weight loss in obese boys and girls. Int J Pediatr Obes
2007; 2: 2-10.
33. Haqq AM, Farooqi IS, O’Rahilly S, Stadler DD,
Rosenfeld RG, Pratt KL, et al. Serum ghrelin levels are inversely
correlated with body mass index, age, and insulin concentrations in normal
children and are markedly increased in Prader–Willi syndrome. J Clin
Endocrinol Metab 2003; 88: 174-178.
34. Yoshinaga M, Sameshima K, Tanaka Y, Wada A,
Hashiguchi J, Tahara H, et al. Adipokines and the prediction of the
accumulation of cardio-vascular risk factors or the presence of metabolic
syndrome in elementary school children. Circ J 2008; 72: 1874-1878.
35. Zhang S, Liu X, Brickman WJ, Christoffel KK,
Zimmerman D, Tsai HJ, Wang G, et al. Association of plasma leptin
concentrations with adiposity measurements in rural Chinese adolescents. J
Clin Endocrinol Metab 2009; 94: 3497-3504.
36. Kim IK, Kim J, Kang JH, Song J. Serum leptin as a
predictor of fatty liver in 7-year-old Korean children. Ann Nutr Metab
2008; 53: 109-116.
37. Licinio J, Caglayan S, Ozata M, Yildiz BO, de
Miranda PB, O’Kirwan F, et al. Phenotypic effects of leptin
replacement on morbid obesity, diabetes mellitus, hypogonadism, and
behavior in leptin-deficient adults. Proc Natl Acad Sci USA 2004; 101:
4531-4536.
38. Aprath-Husmann I, Rohrig K, Gottschling-Zeller H,
Skurk T, Scriba D, Birgel M, et al. Effects of leptin on the
differentiation and metabolism of human adipocytes. Int J Obes Relat Metab
Disord 2001; 25: 1465-1470.
39. Weigle DS, Cummings DE, Newby PD, Breen PA, Frayo
RS, Matthys CC, et al. Roles of leptin and ghrelin in the loss of
body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol
Metab 2003; 88: 1577-1586.
40. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A,
Weimer L, Heymsfield S, et al. Low-dose leptin reverses skeletal
muscle, autonomic, and neuroendocrine adaptations to maintenance of
reduced weight. J Clin Invest 2005; 115: 3579-3586.
41. Cambuli VM, Musiu MC, Incani M, Paderi M, Serpe R,
Marras V, et al. Assessment of adiponectin and leptin as biomarkers
of positive metabolic outcomes after lifestyle intervention in overweight
and obese children. J Clin Endocrinol Metab 2008; 93: 3051-3057.
42. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro
S, Astrup A, et al. Regulation of adiponectin by adipose
tissue-derived cytokines: In vivo and in vitro investigations in humans.
Am J Physiol Endocrinol Metab 2003; 285: E527-533.
43. Panagopoulou P, Galli-Tsinopoulou A, Fleva A,
Pavlitou-Tsiontsi E, Vavatsi-Christaki N, Nousia-Arvanitakis S.
Adiponectin and insulin resistance in childhood obesity. J Pediatr
Gastroenterol Nutr 2008; 47: 356-362.
44. Jeffery AN, Murphy MJ, Metcalf BS, Hosking J, Voss
LD, English P, et al. Adiponectin in childhood. Int J Pediatr Obes
2008; 3: 130-140.
45. Murphy MJ, Hosking J, Metcalf BS, Voss LD, Jeffery
AN, Sattar N, et al. Distribution of adiponectin, leptin, and
metabolic correlates of insulin resistance: a longitudinal study in
British children; 1: Prepuberty (EarlyBird 15). Clin Chem 2008; 54:
1298-1306.
46. Eyzaguirre F, Mericq V. Insulin resistance markers
in children. Horm Res 2009; 71: 65-74.
47. Kadowaki T, Yamauchi T. Adiponectin and adiponectin
receptors. Endocr Rev 2005; 26: 439-451.
48. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H,
Okamoto, et al. Adipocyte-derived plasma protein adiponectin acts
as a platelet-derived growth factor-BB-binding protein and regulates
growth factor-induced common postreceptor signal in vascular smooth muscle
cell. Circulation 2002; 105: 2893-2898.
49. Arnaiz P, Acevedo M, Barja S, Aglony M, Guzman B,
Cassis B, et al. Adiponectin levels, cardio-metabolic risk factors
and markers of subclinical atherosclerosis in children. Int J Cardiol
2008; Sep 5: [Epub ahead of print].
50. Koistinen HA, Bastard JP, Dusserre E, Ebeling P,
Zegari N, Andreelli F, et al. Subcutaneous adipose tissue
expression of tumour necrosis factor-alpha is not associated with whole
body insulin resistance in obese nondiabetic or in type-2 diabetic
subjects. Eur J Clin Invest 2000; 30: 302-310.
51. Hotamisligil GS, Shargill NS, Spiegelman BM.
Adipose expression of tumor necrosis factor-alpha: direct role in
obesity-linked insulin resistance. Science 1993; 259: 87-91.
52. Hotamisligil GS, Spiegelman BM. Tumor necrosis
factor: A key component of the obesity-diabetes link. Diabetes 1994; 43:
1271-1278.
53. Greenberg, AS and McDaniel ML. Identifying the
links between obesity, insulin resistance and ß-cell function: Potential
role of adipocyte-derived cytokines in the pathogenesis of type 2
diabetes. Eur J Clin Invest 2002; 32: 24-34.
54. Angin Y, Kuralay F, Arslan N. Evoluation of
metabolic, antioxidant and oxidant systemic determinants in nonalcoholic
fatty liver disease relevant to pediatric obesity. In: Sahin MF,
Zefirov NS, editors, 1st Turkish-Russian Joint Meeting on Organic and
Medicinal Chemistry; 2009 October 14-17; Antalya, Turkey, p. 64.
55. Lyon CJ, Law RE, Hsueh VA. Minireview: Adiposity,
inflammation, and atherogenesis. Endocrinology 2003; 144: 2195-2200.
56. Gtowinska B, Urban M. Selected cytokines (Il-6,
Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with
atherosclerosis risk factors: obesity, hypertension, diabetes. Wiad Lek
2003; 56: 109-116.
57. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles
JM, Yudkin JS, et al. Subcutaneous adipose tissue releases
interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin
Endocrinol Metab 1997; 82: 4196-4200.
58. Fried SK, Bunkin DA, Greenberg AS. Omental and
subcutaneous adipose tissues of obese subjects release interleukin-6:
depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab
1998; 83: 847-850.
59. Fernandez-Real JM, Vayreda M, Richart C, Gutierrez
C, Broch M, Vendrell J, et al. Circulating interleukin 6 levels,
blood pressure and insulin sensitivity in apparently healthy men and
women. J Clin Endocrinol Metab 2001; 86: 1154-1159.
60. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan
G. Adipose tissue tumor necrosis factor and interleukin-6 expression in
human obesity and insulin resistance. Am J Physiol 2001; 280: 745-751.
61. Yeste D, Vendrell J, Tomasini R, Broch M, Gussinyé
M, Megia A, et al. Interleukin-6 in obese children and adolescents
with and without glucose intolerance. Diabetes Care 2007; 30: 1892-1894.
62. Vozarova B, Weyer C, Hanson K, Tataranni PA,
Bogardus C, Pratley RE. Circulating interleukin-6 in relation to
adiposity, insulin action, and insulin secretion. Obes Res 2001; 9:
414-417.
63. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH.
Plasma concentration of interleukin-6 and the risk of future myocardial
infarction among apparently healthy men. Circulation 2000; 101: 1767-1772.
64. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R,
Mitsiadis CS, Chrousos GP. Dose-dependent effects of recombinant human
interleukin-6 on glucose regulation. J Clin Endocrinol Metab 1997; 82:
4167-4170.
65. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher
M, Klein J, et al. Adiponectin gene expression and secretion is
inhibited by interleukin-6 in 3T3–L1 adipocytes. Biochem Biophys Res
Commun 2003; 301: 1045-1050 .
66. Boden G, Shulman G I. Free fatty acids in obesity
and type 2 diabetes: Defining their role in the development of insulin
resistance and